Comparison of pneumonia incidence between long-acting muscarinic antagonist and inhaled corticosteroid plus long-acting beta agonist in patients with COPD

Few studies have directly compared the incidence of pneumonia in patients on common chronic obstructive pulmonary disease (COPD) treatments such as long-acting muscarinic antagonists (LAMA) with those on inhaled corticosteroids and long-acting β(2)-agonist (ICS/LABA). Moreover, risk factors for pneu...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, Eung Gu, Kim, Youlim, Hwang, Yong Il, Yoo, Kwang Ha, Lee, So Eun, Jung, Kyung Yoon, Lee, Doik, Park, Yong Bum, Rhee, Chin Kook
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199945/
https://www.ncbi.nlm.nih.gov/pubmed/37210420
http://dx.doi.org/10.1038/s41598-023-35223-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10199945/
https://www.ncbi.nlm.nih.gov/pubmed/37210420
http://dx.doi.org/10.1038/s41598-023-35223-3

Ejemplares similares